Mechanistic Aspects and Therapeutic Potential of Quercetin against COVID-19-Associated Acute Kidney Injury

被引:36
|
作者
Diniz, Lucio Ricardo Leite [1 ]
Souza, Marilia Trindade de Santana [2 ]
Duarte, Allana Brunna Sucupira [3 ]
Sousa, Damiao Pergentino de [3 ]
机构
[1] Coll Nordeste Bahia, Dept Nursing, BR-48590000 Coronel Joao Sa, BA, Brazil
[2] Uninassau Univ, Ctr Pharm, BR-49075479 Aracaju, SE, Brazil
[3] Univ Fed Paraiba, Dept Pharmaceut Sci, BR-58051970 Joao Pessoa, PB, Brazil
来源
MOLECULES | 2020年 / 25卷 / 23期
关键词
natural products; medicinal plants; flavonoids; antioxidant; anti-inflammatory activity; nephroprotective activity; renoprotective activity; SARS-CoV; Middle East respiratory syndrome virus; coronavirus; NF-KAPPA-B; RENAL ISCHEMIA/REPERFUSION INJURY; OXIDATIVE STRESS; VIRUS-INFECTION; ANTIOXIDANT PROPERTIES; HEPATITIS-B; RATS; AKI; ACTIVATION; GLOMERULONEPHRITIS;
D O I
10.3390/molecules25235772
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The inflammatory mediator and oxidant agent storm caused by the SARS-CoV-2 infection has been strongly associated with the failure of vital organs observed in critically ill patients with coronavirus disease 2019 (COVID-19) and the death of thousands of infected people around the world. Acute kidney injury (AKI) is a common renal disorder characterized by a sudden and sustained decrease in renal function with a critical influence on poor prognosis and lethal clinical outcomes of various etiologies, including some viral infection diseases. It is known that oxidative stress and inflammation play key roles in the pathogenesis and development of AKI. Quercetin is a natural substance that has multiple pharmacological properties, such as anti-inflammatory action, and is used as a dietary supplement. There is evidence of the anti-coronavirus activities of this compound, including against the target SARS-CoV-2 3CLpro. The ability to inhibit coronavirus and its inflammatory processes is strongly desired in a new drug for the treatment of COVID-19. Therefore, in this review, the dual effect of quercetin is discussed from a mechanistic perspective in relation to AKI kidney injury and its nephroprotective potential to SARS-CoV-2 patients.
引用
收藏
页数:19
相关论文
共 50 条
  • [21] The roles and potential therapeutic implications of C5a in the pathogenesis of COVID-19-associated coagulopathy
    Li, Jing
    Liu, Bin
    CYTOKINE & GROWTH FACTOR REVIEWS, 2021, 58 : 75 - 81
  • [22] COVID-19-associated liver injury: from bedside to bench
    Li, Dongxiao
    Ding, Xiangming
    Xie, Meng
    Tian, Dean
    Xia, Limin
    JOURNAL OF GASTROENTEROLOGY, 2021, 56 (03) : 218 - 230
  • [23] Acute kidney injury in pediatric patients hospitalized with acute COVID-19 and multisystem inflammatory syndrome in children associated with COVID-19
    Basalely, Abby
    Gurusinghe, Shari
    Schneider, James
    Shah, Sareen S.
    Siegel, Linda B.
    Pollack, Gabrielle
    Singer, Pamela
    Castellanos-Reyes, Laura J.
    Fishbane, Steven
    Jhaveri, Kenar D.
    Mitchell, Elizabeth
    Merchant, Kumail
    Capone, Christine
    Gefen, Ashley M.
    Steinberg, Julie
    Sethna, Christine B.
    KIDNEY INTERNATIONAL, 2021, 100 (01) : 138 - 145
  • [24] Quercetin as a potential nutraceutic against coronavirus disease 2019 (COVID-19)
    Moreira Brito, Julio Cesar
    Gustavo Lima, William
    da Cruz Nizer, Waleska Stephanie
    ARS PHARMACEUTICA, 2021, 62 (01) : 85 - 89
  • [25] Longitudinal Follow-Up of Serum and Urine Biomarkers Indicative of COVID-19-Associated Acute Kidney Injury: Diagnostic and Prognostic Impacts
    Lablad, Yahya
    Vanhomwegen, Charlotte
    De Prez, Eric
    Antoine, Marie-Helene
    Hasan, Sania
    Baudoux, Thomas
    Nortier, Joelle
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (22)
  • [26] Prevalence, Characteristics, and Outcomes of COVID-19-Associated Acute Myocarditis
    Ammirati, Enrico
    Lupi, Laura
    Palazzini, Matteo
    Hendren, Nicholas S.
    Grodin, Justin L.
    Cannistraci, Carlo, V
    Schmidt, Matthieu
    Hekimian, Guillaume
    Peretto, Giovanni
    Bochaton, Thomas
    Hayek, Ahmad
    Piriou, Nicolas
    Leonardi, Sergio
    Guida, Stefania
    Turco, Annalisa
    Sala, Simone
    Uribarri, Aitor
    Van de Heyning, Caroline M.
    Mapelli, Massimo
    Campodonico, Jeness
    Pedrotti, Patrizia
    Sanchez, Maria Isabel Barrionuevo
    Sole, Albert Ariza
    Marini, Marco
    Matassini, Maria Vittoria
    Vourc'h, Mickael
    Cannata, Antonio
    Bromage, Daniel, I
    Briguglia, Daniele
    Salamanca, Jorge
    Diez-Villanueva, Pablo
    Lehtonen, Jukka
    Huang, Florent
    Russel, Stephanie
    Soriano, Francesco
    Turrini, Fabrizio
    Cipriani, Manlio
    Bramerio, Manuela
    Di Pasquale, Mattia
    Grosu, Aurelia
    Senni, Michele
    Farina, Davide
    Agostoni, Piergiuseppe
    Rizzo, Stefania
    De Gaspari, Monica
    Marzo, Francesca
    Duran, Jason M.
    Adler, Eric D.
    Giannattasio, Cristina
    Basso, Cristina
    CIRCULATION, 2022, 145 (15) : 1123 - 1139
  • [27] Acute kidney injury and COVID-19
    Horvatic, Ivica
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2022, 54 (06) : 1455 - 1456
  • [28] Impact of COVID-19 on Nephrology Patients: A Mechanistic Outlook for Pathogenesis of Acute Kidney Injury
    Alharbi, Khalid Saad
    Al-Abbasi, Fahad A.
    Agrawal, Gopal Prasad
    Sharma, Ajay
    Kowti, Rajesh
    Kazmi, Imran
    ALTERNATIVE THERAPIES IN HEALTH AND MEDICINE, 2020, 26 : 66 - 71
  • [29] Acute Kidney Injury in COVID-19
    Glowacka, Marta
    Lipka, Sara
    Mlynarska, Ewelina
    Franczyk, Beata
    Rysz, Jacek
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (15)
  • [30] COVID-19 in patients with and without acute kidney injury
    Sabaghian, Tahereh
    Rommasi, Foad
    Omidi, Fatemeh
    Hajikhani, Bahareh
    Nasiri, Mohammad Javad
    Mirsaeidi, Mehdi
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2022, 123 (05): : 372 - 380